Can Regeneron (REGN)’s Rare-Disease Win Move the Earnings Needle?

insidermonkey.com · 2026-08-27

The FDA approved Pasatru, whose generic name is garetosmab, of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for adults with fibrodysplasia ossificans progressiva.

Read the full story at insidermonkey.com →